Furthermore, mIR-34a levels correlate with lipid accumulation and increase hepatic steatosis through reduced fatty acid oxidation and increased mitochondrial damage by targeting SIRT1 [532]. This evidence concerns the gene SIRT1 and fatty liver disease.